Details for New Drug Application (NDA): 020377
✉ Email this page to a colleague
NDA 020377 describes CORDARONE, which is a drug marketed by Wyeth Pharms Inc and Wyeth Pharms and is included in two NDAs. Additional details are available on the CORDARONE profile page.
The generic ingredient in CORDARONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
The generic ingredient in CORDARONE is amiodarone hydrochloride. There are fifteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the amiodarone hydrochloride profile page.
Summary for 020377
| Tradename: | CORDARONE |
| Applicant: | Wyeth Pharms Inc |
| Ingredient: | amiodarone hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020377
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 50MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Aug 3, 1995 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
